Interleukin-12 and interleukin-6 gene polymorphisms and risk of bladder cancer in the Iranian population.

doi:10.7314/apjcp.2014.15.18.7869

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

Interleukin-12 and interleukin-6 gene polymorphisms and risk of bladder cancer in the Iranian population.

Asian Pacific journal of cancer prevention : APJCP - 1 Jan 2014

Ebadi Nader, Jahed Marzieh, Mivehchi Mohamad, Majidizadeh Tayebeh, Asgary Mojgan, Hosseini Seyed Ali

Abstract excerpt

Interleukin-12 (IL-12) as an antitumor and interleukin-6 (IL-6) as an inflammatory cytokine, are immunomodulatory products that play important roles in responses in cancers and inflammation. We tested the association between two polymorphisms of IL-12(1188A>C; rs3212227) and IL-6 (-174 C>G) and the risk of bladder cancer in 261 patients and 251 healthy individuals. We also investigated the possible association of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Follow-Up Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Interleukin-12 Subunit p40

Share to Interleukin-6

Share to Iran

Share to Neoplasm Invasiveness

Share to Neoplasm Staging

Share to Prognosis

Share to Urinary Bladder Neoplasms

Source

Open in PubMed

Identifiers

PMID: 25292079
DOI: 10.7314/apjcp.2014.15.18.7869

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Interleukin-12 and interleukin-6 gene polymorphisms and risk of bladder cancer in the Iranian population.PMID 25292079Read ↗

Association of IL-12, IL-18 variants and serum IL-18 with bladder cancer susceptibility in North Indian population.Semantic proximity Read ↗

IL-6 -174G>C polymorphism and cancer risk: a meta-analysis involving 29,377 cases and 37,739 controls.Semantic proximity Read ↗

Single-nucleotide polymorphisms of the IL-12 gene lead to a higher cancer risk: a meta-analysis based on 22,670 subjects.Semantic proximity Read ↗

Association of interleukin6 rs1800796 gene polymorphism and serum level with bladder cancer in Egyptian population.Semantic proximity Read ↗

Functional polymorphisms in the IL6 gene promoter and the risk of urinary bladder cancer in India.Semantic proximity Read ↗

Investigation of the roles of IL-18 (-607 C/A) and IL-18 (-137 G/C) gene variations in bladder cancer development: case-control study.Semantic proximity Read ↗

Polymorphisms in inflammation genes and bladder cancer: from initiation to recurrence, progression, and survival.Semantic proximity Read ↗

Variability, Expression, and Methylation of IL-6 and IL-8 Genes in Bladder Cancer Pathophysiology.Semantic proximity Read ↗

Interleukin-12: clinical usage and molecular markers of cancer susceptibility.Semantic proximity Read ↗

Functional polymorphisms in the interleukin-12 gene contribute to cancer risk: evidence from a meta-analysis of 18 case-control studies.Semantic proximity Read ↗

Associations of interleukin-6 gene polymorphisms with cancer risk: Evidence based on 49,408 cancer cases and 61,790 controls.Semantic proximity Read ↗

The polymorphisms of IL-4, IL-4R and IL-13 genes and bladder cancer risk in a Chinese population: a case-control study.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.